Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. / Clark, Richard A F; Lin, Fubao; Greiling, Doris; An, Jianqang; Couchman, John R.

In: Journal of Investigative Dermatology, Vol. 122, No. 2, 2004, p. 266-77.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Clark, RAF, Lin, F, Greiling, D, An, J & Couchman, JR 2004, 'Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan.', Journal of Investigative Dermatology, vol. 122, no. 2, pp. 266-77. https://doi.org/10.1046/j.0022-202X.2004.22205.x

APA

Clark, R. A. F., Lin, F., Greiling, D., An, J., & Couchman, J. R. (2004). Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. Journal of Investigative Dermatology, 122(2), 266-77. https://doi.org/10.1046/j.0022-202X.2004.22205.x

Vancouver

Clark RAF, Lin F, Greiling D, An J, Couchman JR. Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. Journal of Investigative Dermatology. 2004;122(2):266-77. https://doi.org/10.1046/j.0022-202X.2004.22205.x

Author

Clark, Richard A F ; Lin, Fubao ; Greiling, Doris ; An, Jianqang ; Couchman, John R. / Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. In: Journal of Investigative Dermatology. 2004 ; Vol. 122, No. 2. pp. 266-77.

Bibtex

@article{b7b7dc50596211dd8d9f000ea68e967b,
title = "Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan.",
abstract = "After tissue injury, fibroblast migration from the peri-wound collagenous stroma into the fibrin-laden wound is critical for granulation tissue formation and subsequent healing. Recently we found that fibroblast transmigration from a collagen matrix into a fibrin matrix required the presence of fibronectin. Several integrins-alpha 4 beta 1, alpha 5 beta 1, and alpha v beta 3-with known fibronectin binding affinity were necessary for this invasive migration. Here we examined another family of cell surface receptors: the proteoglycans. We found that dermatan sulfate was required for fibroblast migration into a fibronectin/fibrin gel. This conclusion was based on beta-xyloside inhibition of glycanation and specific glycosaminoglycan degradation. CD44, a cell surface receptor known to bind hyaluronan, not infrequently exists as a proteoglycan, decorated with various glycosaminoglycan chains including heparan sulfate and chondroitin sulfate, and as such can bind fibronectin. We found that CD44H, the non-spliced isoform of CD44, was necessary for fibroblast invasion into fibronectin/fibrin gels. Resting fibroblasts expressed mostly nonglycanated CD44H core protein, which became glycanated with chondroitin sulfate and dermatan sulfate, but not heparan sulfate, after a 24 h incubation with platelet-derived growth factor, the stimulus used in the migration assay. These results demonstrate that dermatan sulfate-CD44H proteoglycan is essential for fibroblast migration into fibrin clots and that platelet-derived growth factor, the stimulus for migration, induces the production of chondroitin-sulfate- and dermatan-sulfate-glycanated CD44H.",
author = "Clark, {Richard A F} and Fubao Lin and Doris Greiling and Jianqang An and Couchman, {John R}",
note = "Keywords: Adult; Antigens, CD44; Cell Movement; Cells, Cultured; Dermatan Sulfate; Dermis; Extracellular Matrix; Fibrin; Fibroblasts; Fibronectins; Gels; Humans; Platelet-Derived Growth Factor; Proteochondroitin Sulfates; Wound Healing",
year = "2004",
doi = "10.1046/j.0022-202X.2004.22205.x",
language = "English",
volume = "122",
pages = "266--77",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "nature publishing group",
number = "2",

}

RIS

TY - JOUR

T1 - Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan.

AU - Clark, Richard A F

AU - Lin, Fubao

AU - Greiling, Doris

AU - An, Jianqang

AU - Couchman, John R

N1 - Keywords: Adult; Antigens, CD44; Cell Movement; Cells, Cultured; Dermatan Sulfate; Dermis; Extracellular Matrix; Fibrin; Fibroblasts; Fibronectins; Gels; Humans; Platelet-Derived Growth Factor; Proteochondroitin Sulfates; Wound Healing

PY - 2004

Y1 - 2004

N2 - After tissue injury, fibroblast migration from the peri-wound collagenous stroma into the fibrin-laden wound is critical for granulation tissue formation and subsequent healing. Recently we found that fibroblast transmigration from a collagen matrix into a fibrin matrix required the presence of fibronectin. Several integrins-alpha 4 beta 1, alpha 5 beta 1, and alpha v beta 3-with known fibronectin binding affinity were necessary for this invasive migration. Here we examined another family of cell surface receptors: the proteoglycans. We found that dermatan sulfate was required for fibroblast migration into a fibronectin/fibrin gel. This conclusion was based on beta-xyloside inhibition of glycanation and specific glycosaminoglycan degradation. CD44, a cell surface receptor known to bind hyaluronan, not infrequently exists as a proteoglycan, decorated with various glycosaminoglycan chains including heparan sulfate and chondroitin sulfate, and as such can bind fibronectin. We found that CD44H, the non-spliced isoform of CD44, was necessary for fibroblast invasion into fibronectin/fibrin gels. Resting fibroblasts expressed mostly nonglycanated CD44H core protein, which became glycanated with chondroitin sulfate and dermatan sulfate, but not heparan sulfate, after a 24 h incubation with platelet-derived growth factor, the stimulus used in the migration assay. These results demonstrate that dermatan sulfate-CD44H proteoglycan is essential for fibroblast migration into fibrin clots and that platelet-derived growth factor, the stimulus for migration, induces the production of chondroitin-sulfate- and dermatan-sulfate-glycanated CD44H.

AB - After tissue injury, fibroblast migration from the peri-wound collagenous stroma into the fibrin-laden wound is critical for granulation tissue formation and subsequent healing. Recently we found that fibroblast transmigration from a collagen matrix into a fibrin matrix required the presence of fibronectin. Several integrins-alpha 4 beta 1, alpha 5 beta 1, and alpha v beta 3-with known fibronectin binding affinity were necessary for this invasive migration. Here we examined another family of cell surface receptors: the proteoglycans. We found that dermatan sulfate was required for fibroblast migration into a fibronectin/fibrin gel. This conclusion was based on beta-xyloside inhibition of glycanation and specific glycosaminoglycan degradation. CD44, a cell surface receptor known to bind hyaluronan, not infrequently exists as a proteoglycan, decorated with various glycosaminoglycan chains including heparan sulfate and chondroitin sulfate, and as such can bind fibronectin. We found that CD44H, the non-spliced isoform of CD44, was necessary for fibroblast invasion into fibronectin/fibrin gels. Resting fibroblasts expressed mostly nonglycanated CD44H core protein, which became glycanated with chondroitin sulfate and dermatan sulfate, but not heparan sulfate, after a 24 h incubation with platelet-derived growth factor, the stimulus used in the migration assay. These results demonstrate that dermatan sulfate-CD44H proteoglycan is essential for fibroblast migration into fibrin clots and that platelet-derived growth factor, the stimulus for migration, induces the production of chondroitin-sulfate- and dermatan-sulfate-glycanated CD44H.

U2 - 10.1046/j.0022-202X.2004.22205.x

DO - 10.1046/j.0022-202X.2004.22205.x

M3 - Journal article

C2 - 15009704

VL - 122

SP - 266

EP - 277

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 2

ER -

ID: 5160979